International Atomic Energy Agency randomized phase III study of radiation therapy in elderly and/or frail patients with newly diagnosed glioblastoma multiforme

Journal of Clinical Oncology

Volumn 33, Issue 35, 2015, Pages 4145-4150

  Roa, Wilson ^a   Kepka, Lucyna ^b   Kumar, Narendra ^d   Sinaika, Valery ^e   Matiello, Juliana ^f   Lomidze, Darejan ^h   Hentati, Dalenda ⁱ   De Castro, Douglas Guedes ^g   Dyttus Cebulok, Katarzyna ^c   Drodge, Suzanne ^a   Ghosh, Sunita ^a   Jeremić, Branislav ^j   Rosenblatt, Eduardo ^k   Fidarova, Elena ^k  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Warmia and Masuria Oncology Center   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

^d POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^e NN Alexandrov National Cancer Center of Belarus   (Belarus)

^f Irmandade da Santa Casa de Misericordia de Porto Alegre   (Brazil)

^g A C CAMARGO CANCER CENTER   (Brazil)

^h Tbilisi First Hospital   (Georgia)

ⁱ SALAH AZAIEZ INSTITUTE   (Tunisia)

^j Institute of Lung Diseases   (Serbia)

^k INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BRAIN NEOPLASMS; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FRAIL ELDERLY; GLIOBLASTOMA; HUMAN; INTERNATIONAL COOPERATION; KAPLAN MEIER METHOD; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; MULTICENTER STUDY; NUCLEAR ENERGY; PHASE 3 CLINICAL TRIAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FRAIL ELDERLY; GLIOBLASTOMA; HUMANS; INTERNATIONAL AGENCIES; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; NUCLEAR ENERGY; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84957586315     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.62.6606     Document Type: Article

References (25)

1. Dolecek TA, Propp JM, Stroup NE, et al: CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 14:v1-v49, 2012 (suppl 5)
2. Ahlbom A, Rodvall Y: Brain tumor trends. Lancet 2:1272, 1989
3. Shugg D, Allen BJ, Blizzard L, et al: Brain cancer incidence, mortality and case survival: Observations from two Australian cancer registries. Int J Cancer 59:765-770, 1994
4. Boyle P, Maisonneuve P, Saracci R, et al: Is the increased incidence of primary brain tumors in the elderly real? J Natl Cancer Inst 82:1594-1596, 1990
5. Grieg NH, Ries LG, Yancik R, et al: Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 82:1621-1624, 1990
6. Davis L, Ahlbom A, Hohl D, et al: Is brain cancer mortality increasing in industrial countries? Am J Ind Med 19:423-431, 1991
7. Stupp R, Hegi ME, Mason WP, et al: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5 year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459-466, 2009
8. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005
9. Iwamoto FM, Reiner AS, Panageas KS, et al: Patterns of care in elderly glioblastoma patients. Ann Neurol 64:628-634, 2008
10. Kita D, Ciernik IF, Vaccarella S, et al: Age as a predictive factor in glioblastomas: Population-based study. Neuroepidemiology 33:17-22, 2009
11. Paszat L, Laperriere N, Groome P, et al: A population-based study of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 51:100-107, 2001
12. Keime-Guibert F, Chinot O, Taillandier L, et al: Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527-1535, 2007
13. Roa W, Brasher PM, Bauman G, et al: Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial. J Clin Oncol 22:1583-1588, 2004
14. Henriksson R, Asklund T, Poulsen HS: Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: A review. J Neurooncol 104:639-646, 2011
15. Minniti G, Scaringi C, Baldoni A, et al: Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide. Int J Radiat Oncol Biol Phys 86:285-291, 2013
16. Shah PB: Intention-to-treat and per-protocol analysis. CMAJ 183:696, 2011
17. Bleehen NM, Stenning SP: A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br J Cancer 64:769-771, 1991
18. Jeremic B, Shibamoto Y, Grujicic D, et al: Short-course radiotherapy in elderly and frail patients with glioblastoma multiforme: A phase II study. J Neurooncol 44:85-90, 1999
19. Newall J, Ransohoff J, Kaplan B: Glioblastoma in the older patient: How long a course of radiotherapy is necessary? J Neurooncol 6:325-327, 1988
20. Konski A, Bracy P, Weiss S, et al: Cost-utility analysis of a malignant glioma protocol. Int J Radiat Oncol Biol Phys 39:575-578, 1997
21. Bauchet L, Zouaoui S, Darlix A, et al: Assessment and treatment relevance in elderly glioblastoma patients. Neuro Oncol 16:1459-1468, 2014
22. Curran WJ Jr, Scott CB, Horton J, et al: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704-710, 1993
23. Glatstein E, Makuch RW: Illusion and reality: Practical pitfalls in interpreting clinical trials. J Clin Oncol 2:488-497, 1984
24. Simon R: Importance of prognostic factors in cancer clinical trials. Cancer Treat Rep 68:185-192, 1984
25. Li J, Wang M, Won M, et al: Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma. Int J Radiat Oncol Biol Phys 81: 623-630, 2011